About Epic Sciences
Epic Sciences is a company based in San Diego (United States) founded in 2008. Epic Sciences has raised $204.5 million across 7 funding rounds from investors including LabCorp, Roche and ARE. The company has 98 employees as of December 31, 2022. Epic Sciences offers products and services including AR-V7 Test and Biopharma Solutions. Epic Sciences operates in a competitive market with competitors including Guardant Health, GRAIL, Foundation Medicine, ArcherDX and Natera, among others.
- Headquarter San Diego, United States
- Employees 98 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Epic Sciences, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$204.5 M (USD)
in 7 rounds
-
Latest Funding Round
$24 M (USD), Series G
Apr 14, 2023
-
Investors
LabCorp
& 17 more
-
Employee Count
98
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epic Sciences
Epic Sciences offers a comprehensive portfolio of products and services, including AR-V7 Test and Biopharma Solutions.
Liquid biopsy test for prostate cancer therapy selection.
Platform for cancer research and drug development insights.
People of Epic Sciences
Unlock access to complete
Funding Insights of Epic Sciences
Epic Sciences has successfully raised a total of $204.5M across 7 strategic funding rounds. The most recent funding activity was a Series G round of $24 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Epic Sciences
Epic Sciences has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Roche and ARE.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Locked | Locked | Locked | |
|
Private equity investments target specialty industrials and healthcare sectors.
|
Locked | Locked | Locked | |
|
Commercial-ready healthcare innovators are targeted for private equity investments.
|
Locked | Locked | Locked |
Investor details for Epic Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Epic Sciences
Investment portfolio details for Epic Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Epic Sciences
Detailed financials for Epic Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Epic Sciences Comparisons
Peer comparison for Epic Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Epic Sciences
Epic Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Foundation Medicine, ArcherDX and Natera, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Circulating tumor DNA is screened for early cancer detection.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
Detailed competitors of Epic Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Epic Sciences
Complete news archive for Epic Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epic Sciences
Epic Sciences was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Epic Sciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Epic Sciences is a funded company, having raised a total of $204.5M across 7 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Epic Sciences is 98.
Provider of non-invasive tests for the detection of circulating tumor cells. The proprietary platform uses specialized assays and advanced digital pathology algorithms to identify circulating tumor cells from whole blood. The flagship product is Epic AR-V7 which detects the presence of AR-V7 biomarker in whole blood and associates it with the response rate for treatment with Zytiga and Xtandi. The first proposed application is metastatic castration-resistant prostate cancer.
Epic Sciences's top competitors include Guardant Health, GRAIL and Strand Life Sciences.
Epic Sciences offers AR-V7 Test and Biopharma Solutions.
Epic Sciences has 18 investors. Key investors include LabCorp, Roche, ARE, Varian, and Arsenal Capital Partners.